Tags

Phase 2 IPAX-Linz

IPAX-Linz Study Shows Promise for TLX101 Glioma Therapy Candidate

IPAX-Linz Study Shows Promise for TLX101 Glioma Therapy Candidate

April 16, 2025 | 14:29
Telix Pharmaceuticals Limited, today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 in recurrent high-grade glioma.

Latest News

Six localities record double-digit growth as regional performance diverges in 2025

Six localities record double-digit growth as regional performance diverges in 2025

Vietnam’s domestic market to grow 10-12 per cent from 2026-2030

Vietnam’s domestic market to grow 10-12 per cent from 2026-2030

FDI inflows reach $38.42 billion in 2025

FDI inflows reach $38.42 billion in 2025

E-commerce market undergoes transformation amid rising competition and regulation

E-commerce market undergoes transformation amid rising competition and regulation

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Dinh Hung, Bui Duc Hai, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2025 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020